HSE reporting principles

Global reporting initiative

Since 2004, Novartis has reported its HSE performance following the Guidelines for Sustainability Reporting of the Global Reporting Initiative (GRI). The Novartis GRI Report Index – along with a more detailed overview of our HSE performance – is available at: www.novartis.com

 

Reporting entity

HSE performance data for 2007 were collected of the 196 reporting units of the continuing operations around the world, owned and managed by Novartis Group companies. This covers all sites with relevant HSE impacts, including all production, formulation and research and development sites as well as major headquarter offices. Hexal and Eon Labs, which were acquired in 2005, are now fully integrated in the Sandoz Division for all performance management indicators. The former Chiron sites, which were consolidated by Novartis under the new Vaccines and Diagnostics Division in 2006, are now also fully integrated in the Novartis HSE reporting process.

 

Reporting scope

Novartis believes the performance data presented in this Annual Report and on the Novartis website represent a fair and balanced picture of the Novartis HSE performance. Performance Indicators follow GRI requirements for core environmental and social indicators.